Recovery of left ventricular dysfunction after sacubitril/valsartan: predictors and management

•Recovery of left ventricular ejection fraction (LVEF) within 1 year was noted in 18% patients taking sacubitril/valsartan.•Non-ischemic etiology of heart failure and smaller LV size could predict LVEF recovery.•Tapering sacubitril/valsartan in these patients was associated with worse prognosis. Lit...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cardiology 2020-03, Vol.75 (3), p.233-241
Hauptverfasser:	Chang, Hung-Yu, Chen, Kuan-Chun, Fong, Man-Cai, Feng, An-Ning, Fu, Hao-Neng, Huang, Kuan-Chih, Chong, Eric, Yin, Wei-Hsian
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aminobutyrates - therapeutic use Angiotensin Receptor Antagonists - therapeutic use Drug Combinations Female Heart failure Heart Failure - drug therapy Heart Failure - mortality Heart Failure - physiopathology Hospitalization Humans Left ventricular ejection fraction Male Middle Aged Recovery of Function Sacubitril/valsartan Tetrazoles - therapeutic use Ventricular Dysfunction, Left - drug therapy Ventricular Dysfunction, Left - mortality Ventricular Dysfunction, Left - physiopathology Ventricular Function, Left - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!